Clinical trial
Dapagliflozin During Exercise for the Prevention of Hypoglycaemia in Type 1 Diabetes
NCT03537131 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dapagliflozin During Exercise for the Prevention of Hypoglycaemia in Type 1 Diabetes
- Lead sponsor
- University of Oxford
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- June 2, 2018
- Completion date
- July 14, 2021
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.